A next-generation HDAC6 inhibitor for amyotrophic lateral sclerosis and frontotemporal dementia

Journal:

Brain

Published:

2025-10-08

DOI:

10.1093/brain/awaf380

Affiliations:

7

Authors:

17

Go to article

Institutions	Authors	Share
Eikonizo Therapeutics, United States of America (USA)	8.000000	0.47
University of Michigan (U-M), United States of America (USA)	2.000000	0.12
University of Massachusetts Chan Medical School (UMass Chan Medical School), United States of America (USA)	2.000000	0.12
ALS Therapy Development Institute (ALS TDI), United States of America (USA)	2.000000	0.12
PharmaDirections, United States of America (USA)	1.000000	0.06
Neuro/Sys, France	1.000000	0.06
Esya Labs, United Kingdom (UK)	1.000000	0.06

Interested in Neurosciences?